Literature DB >> 6468490

Pharmacokinetics of endralazine.

H L Elliott, P A Meredith, J L Reid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6468490     DOI： 10.1007/bf00543509

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  4 in total

1.  Statistical estimations in pharmacokinetics.

Authors:  H G Boxenbaum; S Riegelman; R M Elashoff
Journal:  J Pharmacokinet Biopharm       Date:  1974-04

2.  Endralazine - a new hydralazine-like antihypertensive with high systemic bioavailability.

Authors:  P A Reece; I Cozamanis; R Zacest
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  Influence of acetylator phenotype on the pharmacokinetics of a new vasodilator antihypertensive, endralazine.

Authors:  P A Reece; I Cozamanis; R Zacest
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  The pharmacokinetics of endralazine in essential hypertensives and in normotensive subjects.

Authors:  P A Meredith; H L Elliott; D R McSharry; A W Kelman; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1983-07       Impact factor: 4.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.